Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Divestments (2022 - 2024)

Historic Divestments for Bioventus (BVS) over the last 3 years, with Q4 2024 value amounting to $24.7 million.

  • Bioventus' Divestments rose 1121621.62% to $24.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $24.7 million, marking a year-over-year decrease of 2883.06%. This contributed to the annual value of $24.7 million for FY2024, which is 2883.06% down from last year.
  • According to the latest figures from Q4 2024, Bioventus' Divestments is $24.7 million, which was up 1121621.62% from -$222000.0 recorded in Q4 2023.
  • Bioventus' 5-year Divestments high stood at $46.4 million for Q3 2023, and its period low was -$104.8 million during Q4 2022.
  • Over the past 3 years, Bioventus' median Divestments value was -$222000.0 (recorded in 2023), while the average stood at -$9.1 million.
  • Within the past 5 years, the most significant YoY rise in Bioventus' Divestments was 1121621.62% (2024), while the steepest drop was 1121621.62% (2024).
  • Bioventus' Divestments (Quarter) stood at -$104.8 million in 2022, then soared by 99.79% to -$222000.0 in 2023, then skyrocketed by 11216.22% to $24.7 million in 2024.
  • Its last three reported values are $24.7 million in Q4 2024, -$222000.0 for Q4 2023, and $46.4 million during Q3 2023.